(Q74827663)
Statements
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy (English)
Rascol O
Sieradzan K
Peyro-Saint-Paul H
Thalamas C
Brefel-Courbon C
Ladure P
Montastruc JL
scientific article published on 01 July 1998